In addition to gut dysbiosis, MS patients have elevated gut permeability and high levels of pro-inflammatory cytokines in their serum, such as IL-1β, TNF-α, and IL-6 to correlate with leaky gut [144]. The gene discussed is IL6; the disease is myeloid sarcoma.